Sprint Trial - Dr. Milan Chag
Channel: Marengo CIMS Hospital
Date: 2016-04-11

Dr. Milan Chag, Cardiologist from CIMS Hospital Ahmedabad introduce a message from Sprint trial in this video. Among hypertensive patients at high risk for CV events but without diabetes, Targeting a SBP of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in: lower rates of fatal and non fatal MACE and death from any cause. There was significantly higher rates of some adverse events Hypotension, electrolyte imbalance and AKI. People with age greater than 75 years also had similar benefit.